Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists (GLP-1RAs)—a class of medications primarily used for weight loss and diabetes ...

Please provide your email address to receive an email when new articles are posted on . At 6 months after randomization, endoscopic sinus surgery patients had significantly reduced SNOT-22 scores vs.

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients; third IL-5 condition indication in the region. Phase 3 trial shows Nucala reduces COPD exacerbations; FDA ...

New research shows that children suffering from chronic sinus disease can benefit from a minimally invasive surgery. Twenty million adults and children in the U.S. have the disease, and their ...

(Reuters) -The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus disease, the drugmakers said on Friday. The approval expands the use ...

ALEXANDRIA, VA —The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the new Clinical Practice Guideline (CPG): Surgical Management of Chronic Rhinosinusitis ...

After a year of treatment with ETI, chronic rhinosinusitis was improved as measured by the Lund-Mackay sinus CT scoring system (decreasing from 5.8 [IQR 5.0-7.0] to 3.3 points [IQR 2.6-4.2]) and the ...